- Trials with a EudraCT protocol (361)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
361 result(s) found for: Visual comparison.
Displaying page 1 of 19.
EudraCT Number: 2016-003329-40 | Sponsor Protocol Number: 15-API-01 | Start Date*: 2017-09-19 | |||||||||||
Sponsor Name:CHU de Nice | |||||||||||||
Full Title: Neovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroid melanoma | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003056-21 | Sponsor Protocol Number: ReCaLL-2013 | Start Date*: 2014-03-19 | |||||||||||
Sponsor Name:GWT-TUD GmbH | |||||||||||||
Full Title: Evaluation of an additional therapeutic approach to diabetic macular edema by combining standard therapy (intravitreal injection of a VEGF‐inhibitor) with micropulse diode laser treatment in a rand... | |||||||||||||
Medical condition: visual impairment due to diabetic macular edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004959-39 | Sponsor Protocol Number: CRFB002A2405 | Start Date*: 2013-05-10 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 24-month, phase IIIb, randomized, double-masked, multicenter study assessing the efficacy and safety of two treatment regimens of 0.5 mg ranibizumab intravitreal injections guided by functional a... | |||||||||||||
Medical condition: Visual impairment due to neovascular AMD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) LT (Prematurely Ended) ES (Prematurely Ended) IE (Prematurely Ended) DE (Prematurely Ended) SK (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) GB (Prematurely Ended) GR (Completed) SE (Completed) FI (Completed) PT (Completed) HU (Completed) NL (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002859-34 | Sponsor Protocol Number: CRFB002E2402 | Start Date*: 2012-04-20 | |||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||||||||||||
Full Title: A 24-month, phase IIIb, open-label, randomized, activecontrolled, 3-arm, multicenter study assessing the efficacy and safety of an individualized, stabilization-criteria-driven PRN dosing regimen w... | |||||||||||||||||||||||
Medical condition: visual impairment due to macular edema secondary to branch retinal occlusion (BRVO) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IE (Completed) GB (Completed) SE (Completed) HU (Completed) CZ (Completed) ES (Completed) SK (Completed) GR (Completed) NL (Completed) PT (Completed) PL (Completed) FR (Completed) IT (Completed) DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001808-37 | Sponsor Protocol Number: 612163 | Start Date*: 2006-09-13 |
Sponsor Name:Royal Devon and Exeter NHS Foundation Trust | ||
Full Title: A randomised controlled trial of fentanyl versus morphine following lower limb arthroplasty | ||
Medical condition: Patients with significant pain following hip or knee arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003061-28 | Sponsor Protocol Number: PDS_Version_1.2 | Start Date*: 2015-09-08 |
Sponsor Name:Vienna Institute for Research in Ocular Surgery | ||
Full Title: Effect of selective alpha 1A receptor antagonists on the iris dilator muscle | ||
Medical condition: Effect of selective alpha 1A receptor antagonists on the iris dilator muscle | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001518-26 | Sponsor Protocol Number: DFI10569 | Start Date*: 2009-03-30 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: Efficacy and safety of oral ataciguat (HMR1766) 200 mg administered once daily for 28 days on pain reduction in patients with Neuropathic Pain. A randomized, double-blind, placebo-controlled, cross... | |||||||||||||
Medical condition: The proposed study is planned to demonstrate that ataciguat 200 mg/day could be effective in reducing neuropathic pain with a good safety profile | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) CZ (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015066-61 | Sponsor Protocol Number: ACT10776 | Start Date*: 2009-12-11 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: Efficacy and safety of SAR407899A in patients with painful diabetic neuropathy. A 28-day, randomized, double-blind, placebo-controlled, parallel-group study. | |||||||||||||
Medical condition: Diabetic peripheral neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015916-16 | Sponsor Protocol Number: 2.707/03/2010 | Start Date*: 2009-11-06 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | ||
Full Title: A Comparison of Postural and Ibopamine Challenges between Progressive and Non-Progressive Glaucoma Patients | ||
Medical condition: Glaucoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-005045-13 | Sponsor Protocol Number: CRFB002EDE20 | Start Date*: 2012-04-26 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: An open-label, multi-center, 6-month extension study comparing the long-term efficacy and safety of Lucentis (Ranibizumab) intravitreal injections versus Ozurdex (Dexamethasone) intravitreal implan... | |||||||||||||
Medical condition: visual impairment due to macular edema following retinal vein occlusion (branch or central) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000808-32 | Sponsor Protocol Number: 1.5 | Start Date*: 2007-09-19 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: A comparison of remifentanil patient-controlled analgesia with epidural analgesia during labor | |||||||||||||
Medical condition: laborpain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017735-18 | Sponsor Protocol Number: UF8573 | Start Date*: 2010-05-28 |
Sponsor Name:CHRU Montpellier - Direction de la Recherche | ||
Full Title: Etude prospective, contrôlée, randomisée du traitement de l’occlusion sévère de la veine centrale de la rétine à sa phase précoce par injection intra-vitréenne de Bevacizumab | ||
Medical condition: retinal vein occlusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002208-32 | Sponsor Protocol Number: PAR06 | Start Date*: 2006-08-14 |
Sponsor Name:York Hospital NHS Trust | ||
Full Title: A comparison of the analgesic efficacy of oral and intravenous paracetamol (perfalgan) in a day case setting | ||
Medical condition: We will perform a double blind randomised comparison of oral paracetamol versus intravenous paracetamol (Perfalgan) in patients undergoing knee arthroscopy in a day surgery setting. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-003873-41 | Sponsor Protocol Number: 14-23-16/07 | Start Date*: 2015-07-09 |
Sponsor Name:MAASTRO Clinic | ||
Full Title: Non invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial | ||
Medical condition: Eligible patients with histologically/cytologically proven primary tumors of the prostate, esophagus, brain or rectum or metastatic disease to the brain (originating from breast, lung or colorectal... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002854-37 | Sponsor Protocol Number: CRFB002DDE26 | Start Date*: 2014-12-23 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A 12-months, randomized, VA-assessor blinded, multicenter, controlled phase IV trial to investigate non-inferiority of two treatment algorithms (discretion of the investigator vs. pro re nata) of 0... | |||||||||||||
Medical condition: Visual impairment due to diabetic macular edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003891-11 | Sponsor Protocol Number: LMT-01-02-18 | Start Date*: 2019-07-16 | |||||||||||
Sponsor Name:Life Molecular Imaging SA | |||||||||||||
Full Title: An Open Label, Single Center Study, to evaluate the Safety and Imaging Characteristics of [18F]PI-2620 as PET Radioligand for Imaging Tau deposition in the brains of subjects with amnestic mild cog... | |||||||||||||
Medical condition: Alzheimer's Disease Amnestic Mild Cognitive Impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003176-12 | Sponsor Protocol Number: A-93-52030-279 | Start Date*: 2014-08-27 | |||||||||||
Sponsor Name:IPSEN S.p.A | |||||||||||||
Full Title: A PHASE II, MULTICENTRE, RANDOMIZED CONTROLLED STUDY EVALUATING THE QUALITY OF LIFE IN PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION TREATED WITH LANREOTIDE AUTOGEL 120 MG IN COMBINATION WIT... | |||||||||||||
Medical condition: Inoperable malignant bowel obstruction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003914-10 | Sponsor Protocol Number: sept2014 | Start Date*: 2015-02-02 |
Sponsor Name:uzleuven | ||
Full Title: ELABORATION OF A PATIENT-FRIENDLY TREATMENT STRATEGY WITH CAPSAICIN NASAL SPRAY IN PATIENTS WITH IDIOPATHIC RHINITIS | ||
Medical condition: idiopathic rhinitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002671-34 | Sponsor Protocol Number: PI20208430057 | Start Date*: 2020-12-04 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity: an open label prospective randomized study | ||
Medical condition: septic shock with hypercontractlity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005638-10 | Sponsor Protocol Number: SST-Pr-2-2005 | Start Date*: 2007-02-12 | |||||||||||
Sponsor Name:University of Münster | |||||||||||||
Full Title: Evaluation of the antipruritic effect of Elidel (pimecrolimus) in non-atopic pruritic disease | |||||||||||||
Medical condition: Prurigo nodularis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
